{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:56:54Z","timestamp":1778273814339,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T00:00:00Z","timestamp":1139875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00125-006-0141-7","type":"journal-article","created":{"date-parts":[[2006,2,13]],"date-time":"2006-02-13T11:39:18Z","timestamp":1139830758000},"page":"434-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":277,"title":["Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review"],"prefix":"10.1007","volume":"49","author":[{"given":"A.","family":"Natali","sequence":"first","affiliation":[]},{"given":"E.","family":"Ferrannini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,2,14]]},"reference":[{"key":"141_CR1","doi-asserted-by":"publisher","first-page":"B47","DOI":"10.1016\/S0149-2918(03)80242-4","volume":"25(Suppl B)","author":"RR Henry","year":"2003","unstructured":"Henry RR (2003) Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes. Clin Ther 25(Suppl B):B47\u2013B63","journal-title":"Clin Ther"},{"key":"141_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1172\/JCI10843","volume":"106","author":"JM Olefsky","year":"2000","unstructured":"Olefsky JM (2000) Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 106:467\u2013472","journal-title":"J Clin Invest"},{"key":"141_CR3","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/BF00400814","volume":"36","author":"LC Groop","year":"1993","unstructured":"Groop LC, Widen E, Ferrannini E (1993) Insulin resistance and insulin deficiency in the pathogenesis of type 2 diabetes (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods. Diabetologia 36:1326\u20131331","journal-title":"Diabetologia"},{"key":"141_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0026-0495(93)90284-U","volume":"42","author":"AB Johnson","year":"1993","unstructured":"Johnson AB, Webster JM, Sum CF et al (1993) The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism 42:1217\u20131222","journal-title":"Metabolism"},{"key":"141_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/diab.43.7.920","volume":"43","author":"G Perriello","year":"1994","unstructured":"Perriello G, Misericordia P, Volpi E et al (1994) Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43:920\u2013928","journal-title":"Diabetes"},{"key":"141_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi SE, Maggs DG, Spollett GR et al (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867\u2013872","journal-title":"N Engl J Med"},{"key":"141_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1210\/endo.131.3.1505458","volume":"131","author":"HS Hundal","year":"1992","unstructured":"Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A (1992) Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131:1165\u20131173","journal-title":"Endocrinology"},{"key":"141_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/1043-6618(94)80104-5","volume":"30","author":"CR Sirtori","year":"1994","unstructured":"Sirtori CR, Pasik C (1994) Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 30:187\u2013228","journal-title":"Pharmacol Res"},{"key":"141_CR9","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.2337\/diabetes.51.12.3479","volume":"51","author":"K H\u00e4llsten","year":"2002","unstructured":"H\u00e4llsten K, Virtanen KA, Lonnqvist F et al (2002) Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes 51:3479\u20133485","journal-title":"Diabetes"},{"key":"141_CR10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","volume":"63","author":"RS Hundal","year":"2003","unstructured":"Hundal RS, Inzucchi SE (2003) Metformin: new understandings, new uses. Drugs 63:1879\u20131894","journal-title":"Drugs"},{"key":"141_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0006-2952(99)00396-2","volume":"59","author":"T Ikeda","year":"2000","unstructured":"Ikeda T, Iwata K, Murakami H (2000) Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol 59:887\u2013890","journal-title":"Biochem Pharmacol"},{"key":"141_CR12","first-page":"532","volume":"20","author":"JC Cuber","year":"1994","unstructured":"Cuber JC, Bosshard A, Vidal H, Vega F, Wiernsperger N, Rapin JR (1994) Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption. Diabetes Metab 20:532\u2013539","journal-title":"Diabetes Metab"},{"key":"141_CR13","first-page":"277","volume-title":"International textbook of diabetes mellitus","author":"E Ferrannini","year":"2004","unstructured":"Ferrannini E, DeFronzo RA (2004) Insulin actions in vivo: glucose metabolism. In: DeFronzo RA, Ferrannini E, Keek H, Zimmet P (eds) International textbook of diabetes mellitus, 3rd edition. John Wiley and Sons, Chichester, pp 277\u2013302","edition":"3"},{"key":"141_CR14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1210\/jc.2002-021786","volume":"88","author":"I Pavo","year":"2003","unstructured":"Pavo I, Jermedy J, Varkonyi TT et al (2003) Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab 88:1637\u20131645","journal-title":"J Clin Endocrinol Metab"},{"key":"141_CR15","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1210\/jc.2003-030861","volume":"89","author":"G Schernthaner","year":"2005","unstructured":"Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P; Quartet Study Group (2005) Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double blind randomized trial. J Clin Endocrinol Metab 89:6068\u20136076","journal-title":"J Clin Endocrinol Metab"},{"key":"141_CR16","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2337\/diabetes.53.6.1621","volume":"53","author":"J Tonelli","year":"2004","unstructured":"Tonelli J, Li W, Kishore P et al (2004) Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 53:1621\u20131629","journal-title":"Diabetes"},{"key":"141_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1445-5994.1991.tb01375.x","volume":"21","author":"HD McIntyre","year":"1991","unstructured":"McIntyre HD, Ma A, Bird DM, Paterson CA, Ravenscroft PJ, Cameron DP (1991) Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus. Aust N Z J Med 21:714\u2013719","journal-title":"Aust N Z J Med"},{"key":"141_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1172\/JCI119628","volume":"100","author":"E Ferrannini","year":"1997","unstructured":"Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100:1166\u20131173","journal-title":"J Clin Invest"},{"key":"141_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1172\/JCI115865","volume":"90","author":"RP Robertson","year":"1992","unstructured":"Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF (1992) Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320\u2013325","journal-title":"J Clin Invest"},{"key":"141_CR20","first-page":"E251","volume":"270","author":"G Boden","year":"1996","unstructured":"Boden G, Ruiz J, Kim CJ, Chen X (1996) Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol 270:E251\u2013E258","journal-title":"Am J Physiol"},{"key":"141_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.33.7.634","volume":"33","author":"WJ Andrews","year":"1984","unstructured":"Andrews WJ, Vasquez B, Nagulesparan M et al (1984) Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33:634\u2013642","journal-title":"Diabetes"},{"key":"141_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2337\/diab.34.3.222","volume":"34","author":"WT Garvey","year":"1985","unstructured":"Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222\u2013234","journal-title":"Diabetes"},{"key":"141_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/diacare.27.6.1349","volume":"27","author":"A Natali","year":"2004","unstructured":"Natali A, Baldeweg S, Toschi E et al (2004) Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 27:1349\u20131357","journal-title":"Diabetes Care"},{"key":"141_CR24","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2337\/diabetes.48.12.2414","volume":"48","author":"JG Yu","year":"1999","unstructured":"Yu JG, Kruszynska YT, Mulford MI, Olefsky JM (1999) A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes 48:2414\u20132421","journal-title":"Diabetes"},{"key":"141_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2337\/diabetes.54.5.1459","volume":"54","author":"HK Karlsson","year":"2005","unstructured":"Karlsson HK, Hallsten K, Bjornholm M et al (2005) Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. Diabetes 54:1459\u20131467","journal-title":"Diabetes"},{"key":"141_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/acta.0.1200257","volume":"120","author":"O Hother-Nielsen","year":"1989","unstructured":"Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O (1989) Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh) 120:257\u2013265","journal-title":"Acta Endocrinol (Copenh)"},{"key":"141_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2337\/diabetes.49.4.633","volume":"49","author":"YT Kruszynska","year":"2000","unstructured":"Kruszynska YT, Yu JG, Olefsky JM, Sobel BE (2000) Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes 49:633\u2013639","journal-title":"Diabetes"},{"key":"141_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/diacare.26.1.172","volume":"26","author":"A Raji","year":"2003","unstructured":"Raji A, Seely EW, Bekins SA, Williams GH, Simonson DC (2003) Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care 26:172\u2013178","journal-title":"Diabetes Care"},{"key":"141_CR29","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","volume":"331","author":"JJ Nolan","year":"1994","unstructured":"Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188\u20131193","journal-title":"N Engl J Med"},{"key":"141_CR30","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/diabetes.51.9.2691","volume":"51","author":"MM Meyer","year":"2002","unstructured":"Meyer MM, Levin K, Grimmsmann T et al (2002) Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. Diabetes 51:2691\u20132697","journal-title":"Diabetes"},{"key":"141_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2337\/diacare.27.1.148","volume":"27","author":"K Levin","year":"2004","unstructured":"Levin K, Hother-Nielsen O, Henriksen JE, Beck-Nielsen H (2004) Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes. Diabetes Care 27:148\u2013154","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0141-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-006-0141-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0141-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0141-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T08:03:53Z","timestamp":1587024233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-006-0141-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,14]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1007\/s00125-006-0141-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,14]]},"assertion":[{"value":"23 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}